(UroToday.com) The 2025 AUA annual meeting featured the IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder cancer, moderated by Dr. Peter Black, with a debate between ...

Adherence to Guidelines-Based Management of Non-Muscle Invasive Bladder Cancer Among Society of Urologic Oncology (SUO) Members - Justin T. Matulay ...

Patient Out-of-Pocket Costs for Guideline-Recommended Treatments for Erectile Dysfunction: A Medicare Cost Modeling Analysis - Beyond the Abstract ...

(UroToday.com) Dr. Sean Elliott, Professor of Urology at the University of Minnesota, delivered a comprehensive and informative presentation addressing the evolving role of urologists in genitourinary ...

(UroToday.com) Sunday afternoon’s plenary session continued with an insightful talk by Dr. José Carlos Truzzi from the Federal University of Sao Paulo. Dr. Truzzi began the session with a brief ...

Prospective Monitoring of Prostate Specific Membrane Antigen (PSMA) –Positive Recurrent Prostate Cancer: Preliminary Data from 6 Months PSMA Follow-Up. Ravi A. Madan, MD Preliminary data from the ...

When Should We Use 18F-FDG PET? "Presentation" - Andrei Iagaru ...

Chicago, IL (UroToday.com) STAMPEDE arm H assessed the efficacy of radiotherapy to the primary in M1 disease 1. This study randomized 2,061 to either standard systemic treatments (ADT +/- chemotherapy ...

The shape and material of external urine collection devices (EUCD) have changed over the past 20 years. Historically, most EUCDs were made from latex that allowed for flexibility but also increased ...

Condition: Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Renal Cell Carcinoma Study ID: NCT05327686 ...

He describes a 67-year-old man with recurrent T1 disease after BCG who refused cystectomy despite high-risk features including lymphovascular invasion. Dr. Tyson outlines multiple treatment options ...